Product Information
LO LOESTRIN FE 1-10 TABLET is a brand product labeled by Allergan, Inc., priced at $6.7661 per EA under NDC 00430042014. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Oct 21, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
LO LOESTRIN FE 1-10 TABLET
norethindrone acetate and ethinyl estradiol, ethinyl estradiol and ferrous fumarateManufacturer
Allergan, Inc.NDC
00430042014
Classification
Brand
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
New Drug (NDA)
FDA Application
NDA022501FDA Approved
10/21/2010
TE Code
AB
On Market Since
12/1/2010
Price Statistics
The NADAC for LO LOESTRIN FE 1-10 TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 135.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.7661 per EA |
|---|---|
| All-time high | $6.7733 (May 13, 2026) |
| All-time low | $2.8518 (Mar 19, 2014) |
| 52-week high | $6.7733 |
| 52-week low | $6.4469 |
| Median price | $5.0603 |
| Average price | $4.9072 |
| Largest weekly change | +9.9% (Jan 13, 2016) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the norethindrone acetate and ethinyl estradiol, ethinyl estradiol and ferrous fumarate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Allergan, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
norethindrone acetate and ethinyl estradiol, ethinyl estradiol and ferrous fumarate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LO LOESTRIN FE 1-10 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LO LOESTRIN FE 1-10 TABLET, manufactured by Allergan, Inc., is $6.7661 per EA (NDC 00430042014), effective Sep 30, 2026.
How has the price of LO LOESTRIN FE 1-10 TABLET changed over time?
Over the history we have for it, the NADAC for LO LOESTRIN FE 1-10 TABLET has risen 135.8%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LO LOESTRIN FE 1-10 TABLET?
Since Nov 28, 2013, the NADAC for LO LOESTRIN FE 1-10 TABLET has ranged from a low of $2.8518 (Mar 19, 2014) to a high of $6.7733 (May 13, 2026), with a median of $5.0603 per EA.
Are there cheaper alternatives to LO LOESTRIN FE 1-10 TABLET?
No other NADAC-published product currently shares the active ingredient and strength of LO LOESTRIN FE 1-10 TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures LO LOESTRIN FE 1-10 TABLET?
LO LOESTRIN FE 1-10 TABLET (NDC 00430042014) is labeled by Allergan, Inc., and CMS classifies it as a brand product.